Indication
Anterior Cruciate Ligament (ACL) Injury
7 clinical trials
9 products
1 drug
Clinical trial
Continuous Vs Single Shot Adductor Canal Block After ACL Reconstruction - A Randomized StudyStatus: Terminated, Estimated PCD: 2022-05-17
Product
BupivacaineClinical trial
Can Platelet Rich Plasma Reduce the Level of Pro-Inflammatory Synovial Fluid Biomarkers Following an Anterior Cruciate Ligament TearStatus: Withdrawn, Estimated PCD: 2024-02-01
Product
Platelet Rich PlasmaClinical trial
Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL ReconstructionStatus: Completed, Estimated PCD: 2023-07-03
Product
Adductor Canal BlockClinical trial
Evaluation of the Effect of Biophysical Stimulation With Pulsed Electromagnetic Fields on Intraspongious Bone Edema in Anterior Cruciate Ligament ReconstructionStatus: Completed, Estimated PCD: 2023-05-26
Product
Anti-inflammatoryClinical trial
Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain. A Randomized Controlled Comparison of the Analgesic Effects Following ACL RepairStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
DexamethasoneClinical trial
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)Status: Recruiting, Estimated PCD: 2025-04-01
Product
MontelukastDrug
VarlilumabProduct
DexmedetomidineClinical trial
The Efficiency and Safety of Platelet-rich Plasma Intra-articular Injections After Anterior Cruciate Ligament Reconstruction: MRI and Clinical Outcome Analysis.Status: Recruiting, Estimated PCD: 2028-04-15
Product
Platelet-rich plasma